|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
37,070,000 |
Market
Cap: |
2.35(B) |
Last
Volume: |
12,537,091 |
Avg
Vol: |
5,815,817 |
52
Week Range: |
$63.44 - $63.44 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-10 |
4 |
S |
$69.12 |
$908,684 |
I/I |
(13,146) |
8,052,102 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-10 |
4 |
S |
$68.70 |
$8,556,110 |
I/I |
(124,542) |
8,062,934 |
|
- |
|
Cole G Bradley |
CFO |
|
2019-04-09 |
4 |
AS |
$67.59 |
$1,014,120 |
I/I |
(15,000) |
43,722 |
|
- |
|
Cole G Bradley |
CFO |
|
2019-04-09 |
4 |
OE |
$17.18 |
$315,700 |
I/I |
15,000 |
58,722 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-09 |
4 |
S |
$67.68 |
$1,425,885 |
I/I |
(21,063) |
8,165,552 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-08 |
4 |
S |
$67.90 |
$1,537,720 |
I/I |
(22,648) |
8,182,908 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2019-04-08 |
4 |
AS |
$66.72 |
$669,321 |
I/I |
(10,000) |
108,952 |
|
- |
|
Vaughn James J |
Chief Commercial Officer |
|
2019-04-08 |
4 |
AS |
$67.18 |
$203,179 |
D/D |
(3,000) |
23,164 |
|
- |
|
Vaughn James J |
Chief Commercial Officer |
|
2019-04-08 |
4 |
OE |
$31.12 |
$93,360 |
D/D |
3,000 |
26,164 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-05 |
4 |
S |
$68.63 |
$5,333,397 |
I/I |
(77,648) |
8,201,569 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-04 |
4 |
S |
$66.64 |
$5,401,339 |
I/I |
(81,053) |
8,265,548 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-04-03 |
4 |
S |
$68.90 |
$6,701,717 |
I/I |
(97,269) |
8,332,332 |
|
- |
|
Baker Bros. Investments, L.p. |
Director |
|
2019-04-01 |
4 |
A |
$66.84 |
$119,510 |
I/I |
1,788 |
8,412,478 |
|
- |
|
Graham Ginger L |
Director |
|
2019-04-01 |
4 |
A |
$66.84 |
$9,959 |
I/I |
149 |
51,952 |
|
- |
|
Fuchs Henry J |
Director |
|
2019-04-01 |
4 |
A |
$66.84 |
$9,959 |
D/D |
149 |
6,481 |
|
- |
|
Cohen Fred E |
Director |
|
2019-04-01 |
4 |
A |
$66.84 |
$9,959 |
D/D |
149 |
67,768 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-04-01 |
4 |
AS |
$66.94 |
$1,694,059 |
I/I |
(25,000) |
258,479 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2019-03-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
7,000 |
118,952 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-29 |
4 |
AS |
$69.03 |
$1,734,470 |
I/I |
(25,000) |
283,479 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2019-03-28 |
4 |
AS |
$68.21 |
$1,713,259 |
I/I |
(25,000) |
308,479 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-21 |
4 |
S |
$74.71 |
$4,232,164 |
I/I |
(56,651) |
8,412,180 |
|
- |
|
Pla Frederic |
COO |
|
2019-03-19 |
4 |
AS |
$75.00 |
$352,500 |
D/D |
(4,700) |
31,575 |
|
- |
|
Pla Frederic |
COO |
|
2019-03-19 |
4 |
OE |
$27.00 |
$135,234 |
D/D |
4,700 |
36,275 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-19 |
4 |
S |
$74.34 |
$3,724,594 |
I/I |
(50,100) |
8,458,858 |
|
- |
|
Baker Bros. Investments Ii, L.p. |
Director |
|
2019-03-19 |
4 |
S |
$74.63 |
$7,845,648 |
I/I |
(105,126) |
8,500,139 |
|
- |
|
713 Records found
|
|
Page 5 of 29 |
|
|